找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Aortic Root Surgery; The Biological Solut Charles A. Yankah (Professor of Surgery Consutant Book 2010 The Editor(s) (if applicable) and Th

[復(fù)制鏈接]
樓主: 要求
21#
發(fā)表于 2025-3-25 06:26:17 | 只看該作者
22#
發(fā)表于 2025-3-25 07:37:55 | 只看該作者
Using BioGlue to achieve hemostasis in aortic root surgerydrome who underwent aortic root replacement, 9% of patients required mediastinal reexploration to treat bleeding [.]. In another recent report, the incidence of bleeding requiring reoperation was 12.9% in a series of 132 patients who underwent root replacement with porcine aortic root xenografts [.].
23#
發(fā)表于 2025-3-25 12:16:54 | 只看該作者
24#
發(fā)表于 2025-3-25 19:28:54 | 只看該作者
25#
發(fā)表于 2025-3-25 20:43:23 | 只看該作者
Aortic annuloplastyy shortening the circumference of its annulus” [.]. However, in practical surgical situations, a valve annulus can either be enlarged or reduced. Accordingly, we will discuss reduction and augmentation aortic annuloplasty in this chapter.
26#
發(fā)表于 2025-3-26 00:24:45 | 只看該作者
Percutaneous transluminal aortic valve replacement: The CoreValve prosthesisith a single diseased valve were declined for surgery or were never considered as surgical candidates, due to an expected short life expectancy and associated comorbid conditions [.]. alternative techniques for treatment of high-risk patients are therefore needed.
27#
發(fā)表于 2025-3-26 08:15:29 | 只看該作者
From minimally invasive to percutaneous aortic valve replacement has shifted with the majority of diseased valves being replaced by a bioprosthesis today [.]. In contrast to coronary surgery where the decline in the number of operations has been accompanied by a rising procedural volume of percutaneous coronary interventions (PCI) since the late 1990s, valve sur
28#
發(fā)表于 2025-3-26 08:36:03 | 只看該作者
29#
發(fā)表于 2025-3-26 16:33:49 | 只看該作者
Yacoub/David techniques for aortic root operation: success and failuresith fibrous, elastic, nervous, and muscular properties [., ., .]. No such thin, but at the same time strong and non-thrombogeneic material can be produced in laboratories and even less by industrial processes.
30#
發(fā)表于 2025-3-26 19:20:53 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 08:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
巍山| 城市| 贵德县| 台安县| 耿马| 区。| 天等县| 广宗县| 思茅市| 台江县| 巴楚县| 西昌市| 无为县| 馆陶县| 武胜县| 芦溪县| 屏东市| 临沭县| 云安县| 遵化市| 平潭县| 扎囊县| 张家港市| 富民县| 上虞市| 淮滨县| 麻阳| 南皮县| 股票| 卓资县| 绍兴县| 安图县| 泗洪县| 辽源市| 卢湾区| 胶南市| 禹城市| 泗阳县| 涞水县| 迁安市| 庆阳市|